Hippuric Acid

Hippuric Acid

SCHEMBL7796688

N.O=C(O)CNC(=O)c1ccccc1

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TPH1TPH2

The experimentally established mechanism targets of Hippuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.66
▸ MAPT P10636 1/20 0.66
▸ HIF1A Q16665 1/20 0.66
▸ SLC22A6 Q4U2R8 1/20 0.66
▸ SLC22A8 Q8TCC7 1/20 0.66
▸ GAA P10253 1/20 0.65
▸ CA1 P00915 2/20 0.58
▸ CA2 P00918 1/20 0.58
▸ PTPRC P08575 2/20 0.56
▸ CTSL P07711 1/20 0.56
▸ PTPN13 Q12923 1/20 0.56
▸ ATM Q13315 1/20 0.54
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ GPR139 Q6DWJ6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hippuric Acid SCHEMBL657588 1.00 KDM4E (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL428479 0.98 GAA (0.68) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL22030672 0.98 GAA (0.68) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL7486 0.98 GAA (0.68) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL1458080 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL21569381 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL1179259 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL3448563 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL7398337 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8
Hippuric Acid SCHEMBL11656206 0.96 MAPT (0.66) KDM4EMAPTHIF1ASLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107921112-A methods of modulating L GA L S3BP for treatment of systemic lupus erythematosus 默克专利有限公司 2018-04-17 — — CN claimed
US-20130234071-A1 COMPOSITION OF HUMAN SYNTHETIC URINE DENEAU JOEL DAVID (US) 2013-09-12 — — US claimed
US-6319683-B1 CARBONYLATION WITH FORMALDEHYDE INTERGEN COMPANY 2001-11-20 — — US claimed
US-20010031482-A1 Method and composition for controlling formaldehyde fixation by delayed quenching JAMES WILLIAM M (US) 2001-10-18 — — US claimed
US-6072086-A QUENCHING AQUEOUS FORMALDEHYDE SOLUTION WITH COMPOSITION COMPRISING FIRST AGENT CAPABLE OF REACTING WITH FORMALDEHYDE, SECOND AGENT CAPABLE OF SUBSTANTIALLY PREVENTING FIRST AGENT FROM REACTING WITH FORMALDEHYDE FOR FINITE TIME PERIOD INTERGEN COMPANY (US) 2000-06-06 — — US claimed
EP-0900367-A1 METHOD AND COMPOSITION FOR CONTROLLING FORMALDEHYDE FIXATION BY DELAYED QUENCHING ONCOR, INC. (US) 1999-03-10 — — EP claimed
WO-1997039330-A1 METHOD AND COMPOSITION FOR CONTROLLING FORMALDEHYDE FIXATION BY DELAYED QUENCHING ONCOR, INC. (US) 1997-10-23 — — WO claimed
US-20250135061-A1 Devices for Retaining Bodily Fluids with pH Control Components CUPRON, INC. (US) 2025-05-01 — — US disclosed
CN-118714929-A Device for trapping body fluids with pH controlling component 科普隆有限公司 2024-09-27 — — CN disclosed
EP-4376619-A1 DEVICES FOR RETAINING BODILY FLUIDS WITH PH CONTROL COMPONENTS Cupron Inc. (US) 2024-06-05 — — EP disclosed
WO-2024035380-A1 DEVICES FOR RETAINING BODILY FLUIDS WITH PH CONTROL COMPONENTS CUPRON INC. (US) 2024-02-15 — — WO disclosed
CN-107074768-A The Pyridione derivatives of (RET) kinase inhibitor are reset as transfection 葛兰素史克知识产权发展有限公司 2017-08-18 — — CN disclosed
US-9117756-B2 Encapsulant with corrosion inhibitor FREESCALE SEMICONDUCTOR, INC. (US) 2015-08-25 — — US disclosed
US-20130193576-A1 ENCAPSULANT WITH COROSION INHIBITOR NXP, B.V. F/K/A FREESCALE SEMICONDUCTOR, INC. (NL) 2013-08-01 — — US disclosed
EP-2620979-A2 Encapsulant with corosion inhibitor Freescale Semiconductor, Inc. (US) 2013-07-31 — — EP disclosed
US-6319683-B1 CARBONYLATION WITH FORMALDEHYDE INTERGEN COMPANY 2001-11-20 — — US disclosed
US-20010031482-A1 Method and composition for controlling formaldehyde fixation by delayed quenching JAMES WILLIAM M (US) 2001-10-18 — — US disclosed
US-6072086-A QUENCHING AQUEOUS FORMALDEHYDE SOLUTION WITH COMPOSITION COMPRISING FIRST AGENT CAPABLE OF REACTING WITH FORMALDEHYDE, SECOND AGENT CAPABLE OF SUBSTANTIALLY PREVENTING FIRST AGENT FROM REACTING WITH FORMALDEHYDE FOR FINITE TIME PERIOD INTERGEN COMPANY (US) 2000-06-06 — — US disclosed
EP-0900367-A1 METHOD AND COMPOSITION FOR CONTROLLING FORMALDEHYDE FIXATION BY DELAYED QUENCHING ONCOR, INC. (US) 1999-03-10 — — EP disclosed
WO-1997039330-A1 METHOD AND COMPOSITION FOR CONTROLLING FORMALDEHYDE FIXATION BY DELAYED QUENCHING ONCOR, INC. (US) 1997-10-23 — — WO disclosed
Send feedback